Key positives include a much stronger liquidity position, substantially lower debt, and a return to positive equity, which together reduce near-term financial stress. The company has narrowed its losses compared with the worst years, showing that costs can be cut when needed. Strategically, Akanda now has footholds in two sectors with structural growth drivers: medical cannabis in the UK and telecom infrastructure in Mexico. Its access to critical infrastructure contracts and its ambition to differentiate cannabis offerings through technology are meaningful strategic assets if they can be converted into stable revenue and margins.

The main concerns are persistent losses, chronically negative cash flow, and highly volatile revenue. The business is not yet self-sustaining and still depends heavily on external financing and shareholder dilution; the history of multiple reverse splits underscores this financial strain. The dual-sector model adds complexity and execution risk, as management must simultaneously scale a regulated healthcare distribution business and an infrastructure-heavy telecom platform. Regulatory shifts in either cannabis or telecom could materially affect operations, and the company’s small scale leaves limited room for missteps.

Akanda’s outlook is that of a high-uncertainty transformation story. The cleaned-up balance sheet provides a window of time to pursue its new strategy, but the path to sustainable profitability and positive cash flow is not yet visible in the historical numbers. Future performance will hinge on stabilizing and growing revenue in both segments, proving that the telecom contracts and cannabis technology platforms can produce durable, cash-generative operations, and maintaining access to capital until that happens. Observers will likely focus on revenue consistency, margin trends, and cash burn over the next several reporting periods to gauge whether the strategic pivot is taking hold.